D R Abernethy
- Pharmacology top 1%
- Pharmacology top 5%
- Pediatrics, Perinatology and Child Health top 10%
- Oncology
- Psychiatry and Mental health top 10%
- Co-authors
- Richard I. ShaderDavid J. GreenblattMarcia DivollBarbara AmeerNabil AndrawisTracey DickinsonJ S HarmatzD J Greenblatt
- Topics
- Pharmacogenetics and Drug Metabolism (7 papers)Drug-Induced Hepatotoxicity and Protection (5 papers)Pharmaceutical studies and practices (5 papers)
- Journals
- Biochemical and Biophysical Research CommunicationsJournal of Pharmacology and Experimental TherapeuticsAnesthesiology
- Partner nations
- United StatesSwitzerlandGermany
In The Last Decade
D R Abernethy
30 papers receiving 924 citations
Peers
Comparison fields: 5 of 99
- Pharmacology 278
- Pharmacology 204
- Pediatrics, Perinatology and Child Health 182
- Oncology 155
- Psychiatry and Mental health 149
Countries citing papers authored by D R Abernethy
This map shows the geographic impact of D R Abernethy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D R Abernethy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D R Abernethy more than expected).
Fields of papers citing papers by D R Abernethy
This network shows the impact of papers produced by D R Abernethy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D R Abernethy. The network helps show where D R Abernethy may publish in the future.
Co-authorship network of co-authors of D R Abernethy
This figure shows the co-authorship network connecting the top 25 collaborators of D R Abernethy. A scholar is included among the top collaborators of D R Abernethy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D R Abernethy. D R Abernethy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 57 | |
| 2 | 47 | |
| 3 | Polymorphic variant endothelial nitric oxide synthase impairs endothelium dependent vascular relaxation in both heterozygotes and homozygotes | 4 |
| 4 | 11 | |
| 5 | 43 | |
| 6 | 12 | |
| 7 | 17 | |
| 8 | 32 | |
| 9 | 13 | |
| 10 | 6 | |
| 11 | 18 | |
| 12 | Liver injury due to verapamil. | 10 |
| 13 | 18 | |
| 14 | 4 | |
| 15 | 82 | |
| 16 | 12 | |
| 17 | 114 | |
| 18 | 32 | |
| 19 | 124 | |
| 20 | 66 |
About D R Abernethy
D R Abernethy is a scholar working on Pharmacology, Analytical Chemistry and Pediatrics, Perinatology and Child Health, having authored 31 papers that have together received 981 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (7 papers), Drug-Induced Hepatotoxicity and Protection (5 papers) and Pharmaceutical studies and practices (5 papers). The work is most often cited by research in Pharmacology (278 citations), Pharmacology (204 citations) and Anesthesiology and Pain Medicine (66 citations). D R Abernethy has collaborated with scholars based in United States, Switzerland and Germany. Frequent co-authors include Richard I. Shader, David J. Greenblatt, Marcia Divoll, Barbara Ameer, Nabil Andrawis, Tracey Dickinson, J S Harmatz, D J Greenblatt, JM Egan and Irving W. Wainer. Their work appears in journals such as Biochemical and Biophysical Research Communications, Journal of Pharmacology and Experimental Therapeutics and Anesthesiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.